// App-Quantinova.ai

TCT-282 : Risk Factors Associated with Adverse Events during Chronic Total Occlusion Percutaneous Coronary Interventions: A sub-Analysis of the OPEN-CTO Study

Researchers

Presenter

  • Robert Riley

Principal Investigators

  • James Sapontis

  • Philip Jones

  • Ajay Kirtane

  • Robert Yeh

  • Dimitri Karmpaliotis

  • J. Aaron Grantham

  • William Lombardi

  • Emmanouil Brilakis

  • James McCabe

Medical Centers

  • Massachusetts General Hospital, Boston, MA, United States

  • VA North Texas Healthcare System and UT Southwestern Medical Center, Dallas, TX

  • Newyork Presbyterian Hospital, Newyork, New York, United States

  • Columbia University, New York, New York, United States

  • University of Washington, Seattle, WA, United States

  • University of Washington Health Sciences, Seattle, Washington, United States

  • MonashHeart, Victoria, Victoria, Australia

  • University of Missouri Kansas City and Mid America Heart Institute, Kansas City, Missouri, United States

Locations

  • United States

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Contrast-induced Acute Kidney Injury

  • Chronic total occlusion

  • Coronary perforation

  • Cardiogenic shock

  • Renal disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved